416 related articles for article (PubMed ID: 17925492)
61. Megakaryopoiesis and thrombopoiesis: an update on cytokines and lineage surface markers.
Yu M; Cantor AB
Methods Mol Biol; 2012; 788():291-303. PubMed ID: 22130715
[TBL] [Abstract][Full Text] [Related]
62. Shared roles for
Chiu SK; Orive SL; Moon MJ; Saw J; Ellis S; Kile BT; Huang Y; Chacon D; Pimanda JE; Beck D; Hamilton JR; Tremblay CS; Curtis DJ
Blood; 2019 Sep; 134(10):826-835. PubMed ID: 31300405
[TBL] [Abstract][Full Text] [Related]
63. Regulatory effects of TLR2 on megakaryocytic cell function.
Beaulieu LM; Lin E; Morin KM; Tanriverdi K; Freedman JE
Blood; 2011 Jun; 117(22):5963-74. PubMed ID: 21454454
[TBL] [Abstract][Full Text] [Related]
64. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.
Mazharian A; Mori J; Wang YJ; Heising S; Neel BG; Watson SP; Senis YA
Blood; 2013 May; 121(20):4205-20. PubMed ID: 23509158
[TBL] [Abstract][Full Text] [Related]
65. ADAP deficiency impairs megakaryocyte polarization with ectopic proplatelet release and causes microthrombocytopenia.
Spindler M; van Eeuwijk JMM; Schurr Y; Nurden P; Nieswandt B; Stegner D; Reinhold A; Bender M
Blood; 2018 Aug; 132(6):635-646. PubMed ID: 29950291
[TBL] [Abstract][Full Text] [Related]
66. A critical role for the transcription factor Scl in platelet production during stress thrombopoiesis.
McCormack MP; Hall MA; Schoenwaelder SM; Zhao Q; Ellis S; Prentice JA; Clarke AJ; Slater NJ; Salmon JM; Jackson SP; Jane SM; Curtis DJ
Blood; 2006 Oct; 108(7):2248-56. PubMed ID: 16763211
[TBL] [Abstract][Full Text] [Related]
67. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo.
Fock EL; Yan F; Pan S; Chong BH
Exp Hematol; 2008 Jan; 36(1):78-92. PubMed ID: 17923245
[TBL] [Abstract][Full Text] [Related]
68. Role of focal adhesion tyrosine kinases in GPVI-dependent platelet activation and reactive oxygen species formation.
Carrim N; Walsh TG; Consonni A; Torti M; Berndt MC; Metharom P
PLoS One; 2014; 9(11):e113679. PubMed ID: 25415317
[TBL] [Abstract][Full Text] [Related]
69. Deletion of Grin1 in mouse megakaryocytes reveals NMDA receptor role in platelet function and proplatelet formation.
Hearn JI; Green TN; Hisey CL; Bender M; Josefsson EC; Knowlton N; Baumann J; Poulsen RC; Bohlander SK; Kalev-Zylinska ML
Blood; 2022 Apr; 139(17):2673-2690. PubMed ID: 35245376
[TBL] [Abstract][Full Text] [Related]
70. The relationship between megakaryocyte ploidy and platelet volume in normal and thrombocytopenic C3H mice.
Corash L; Levin J
Exp Hematol; 1990 Oct; 18(9):985-9. PubMed ID: 2397753
[TBL] [Abstract][Full Text] [Related]
71. Determinants of platelet number and regulation of thrombopoiesis.
Kaushansky K
Hematology Am Soc Hematol Educ Program; 2009; ():147-52. PubMed ID: 20008193
[TBL] [Abstract][Full Text] [Related]
72. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
Deutsch VR; Tomer A
Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
[TBL] [Abstract][Full Text] [Related]
73. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function.
White MJ; Schoenwaelder SM; Josefsson EC; Jarman KE; Henley KJ; James C; Debrincat MA; Jackson SP; Huang DC; Kile BT
Blood; 2012 May; 119(18):4283-90. PubMed ID: 22294729
[TBL] [Abstract][Full Text] [Related]
74. Caspase activation is involved in early megakaryocyte differentiation but not in platelet production from megakaryocytes.
Kozuma Y; Yuki S; Ninomiya H; Nagasawa T; Kojima H
Leukemia; 2009 Jun; 23(6):1080-6. PubMed ID: 19212331
[TBL] [Abstract][Full Text] [Related]
75. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
76. Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.
Wang W; Oh S; Koester M; Abramowicz S; Wang N; Tall AR; Welch CL
Circ Cardiovasc Genet; 2016 Jun; 9(3):213-22. PubMed ID: 27098250
[TBL] [Abstract][Full Text] [Related]
77. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
78. Differential effects of human granulocyte colony-stimulating factor (hG-CSF) and thrombopoietin on megakaryopoiesis and platelet function in hG-CSF receptor-transgenic mice.
Yang FC; Tsuji K; Oda A; Ebihara Y; Xu MJ; Kaneko A; Hanada S; Mitsui T; Kikuchi A; Manabe A; Watanabe S; Ikeda Y; Nakahata T
Blood; 1999 Aug; 94(3):950-8. PubMed ID: 10419886
[TBL] [Abstract][Full Text] [Related]
79. Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans.
Beaulieu LM; Lin E; Mick E; Koupenova M; Weinberg EO; Kramer CD; Genco CA; Tanriverdi K; Larson MG; Benjamin EJ; Freedman JE
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):552-64. PubMed ID: 24458711
[TBL] [Abstract][Full Text] [Related]
80. Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production.
Abraham M; Weiss ID; Wald H; Wald O; Nagler A; Beider K; Eizenberg O; Peled A
Br J Haematol; 2013 Oct; 163(2):248-59. PubMed ID: 23906028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
